Any current/future new fundraising through debt or equity?

No major greenfield or brownfield investments planned currently, indicating limited immediate large-scale capital requirements. Capital expenditure for FY26 is expected around Rs. 75 crore to 100 crore, mainly for solar projects, R&D, and sustenance CAPEX. No specific mention of new fundraising through debt or equity during the call. Focus remains on improving capital efficiency and optimizing overhead costs. The company is managing capital allocation carefully, with a healthy cash and liquid fund balance of Rs. 439 crore as of March 31, 2025. Any major fundraising plans, if any, were not disc

Any current/future capex/capital investment/strategic investment?

No major greenfield or brownfield capital investments are planned currently. Sustenance CAPEX continues for maintenance and repair of plants and machinery. Planned investments include: - Solar power projects, specifically at the Dahej site. - Increased spending on R&D capabilities. FY26 capital expenditure outlook is estimated around Rs. 75-100 crore, primarily for sustenance and strategic areas mentioned. Multiple new conversations and explorations for the MPP (Multi-Purpose Project) are ongoing amidst tariff and market complexities but no specific commitments yet.

Future growth expectations in sales/revenue/volumes?

Seed business expected to continue improving from current levels with a positive domestic outlook. Soil and plant health business projected to grow further, complementing overall growth. Addition of new herbicide portfolio anticipated to drive significant traction and revenue growth. Domestic crop care business aims to grow faster than the industry average of 5-7%, targeting both volume and price increases. Efforts focus on expanding market share through portfolio gap filling, especially herbicides like ‘LAAFA,’ and enhanced farmer engagement. Export business growth remains dynamic a

Future growth expectations in earnings/operating earnings/profits/EPS?

Rallis India aims to grow faster than the industry average of 5-7%, driven by volume growth and price/mix improvements. The seed business is expected to continue improving, notably with strong momentum in new cotton hybrids (over 1 million packets sold). Soil and plant health and herbicide segments are targeted for double-digit growth; soil and plant health grew 23% and herbicide 24% recently. Margin efforts focus on maintaining or improving EBITDA margins through efficient operations and market share gains. CAPEX will focus on sustaining R&D and solar projects, with an estimated INR 75-100 cr

Current/ Expected Orderbook/ Pending Orders?

The transcript does not explicitly mention the current or expected order book or pending orders. There is a reference to deferment of some customer consignments in CSM business, causing softness in that segment. Discussions mention ongoing efforts to reset relationships and explore new ideas in the export/CSM business, indicating some uncertainty in order flow. Domestic demand appears positive with expectations of a normal to above-normal monsoon aiding demand for the 2025 season. Export business has seen some recovery with a 6% growth in volume and price in Q4, suggesting improving order flow

IN US

Sale is live|00:00:00left today

Rallis India LtdQ1 FY25Fertilizers & Agrochemicals

Rallis India Ltd Q1 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹231P/E: 25.6Market Cap: ₹5.2K CrSector: Fertilizers & Agrochemicals

Management growth scorecard

Revenue

Category 4

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

0 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 4

→Seed business expected to continue improving from current levels with a positive domestic outlook.
→Soil and plant health business projected to grow further, complementing overall growth.
→Addition of new herbicide portfolio anticipated to drive significant traction and revenue growth.
→Domestic crop care business aims to grow faster than the industry average of 5-7%, targeting both volume and price increases.
→Efforts focus on expanding market share through portfolio gap filling, especially herbicides like ‘LAAFA,’ and enhanced farmer engagement.
→Export business growth remains dynamic and uncertain due to geopolitical and tariff challenges but holds long-term potential with new partnerships.
→Overall, company targets competitive, profitable, and sustainable growth with consistent improvements across segments.
→Growth guidance suggests aiming for faster-than-industry growth, qualitatively around or above 10% revenue growth internally targeted.

Margin guidance

Category 3

→Rallis India aims to grow faster than the industry average of 5-7%, driven by volume growth and price/mix improvements.
→The seed business is expected to continue improving, notably with strong momentum in new cotton hybrids (over 1 million packets sold).
→Soil and plant health and herbicide segments are targeted for double-digit growth; soil and plant health grew 23% and herbicide 24% recently.
→Margin efforts focus on maintaining or improving EBITDA margins through efficient operations and market share gains.
→CAPEX will focus on sustaining R&D and solar projects, with an estimated INR 75-100 crore planned for FY26.
→Export business remains dynamic with ongoing recalibration amid U.S. tariffs; recovery signs are emerging, but challenges persist in CSM.
→Overall, management is positive on driving competitive, profitable, and sustainable growth to create stakeholder value.

3 more insights locked — sign up free to unlock

Fundraise plans

→No major greenfield or brownfield investments planned currently, indicating limited immediate large-scale capital requirements.
→Capital expenditure for FY26 is expected around Rs. 75 crore to 100 crore, mainly for solar projects, R&D, and sustenance CAPEX.
→No specific mention of new fundraising through debt or equity during the call.
→Focus remains on improving capital efficiency and optimizing overhead costs.
→The company is managing capital allocation carefully, with a healthy cash and liquid fund balance of Rs. 439 crore as of March 31, 2025.
→Any major fundraising plans, if any, were not disclosed or indicated in the discussed transcript.

Order book

→The transcript does not explicitly mention the current or expected order book or pending orders.
→There is a reference to deferment of some customer consignments in CSM business, causing softness in that segment.
→Discussions mention ongoing efforts to reset relationships and explore new ideas in the export/CSM business, indicating some uncertainty in order flow.
→Domestic demand appears positive with expectations of a normal to above-normal monsoon aiding demand for the 2025 season.
→Export business has seen some recovery with a 6% growth in volume and price in Q4, suggesting improving order flow.
→Overall, while exact numbers are not provided, the company is cautiously optimistic about future orders, focusing on market share growth and efficient operations amidst tariff and geopolitical challenges.

Capex plans

→No major greenfield or brownfield capital investments are planned currently.
→Sustenance CAPEX continues for maintenance and repair of plants and machinery.
→Planned investments include:
→ - Solar power projects, specifically at the Dahej site.
→ - Increased spending on R&D capabilities.
→FY26 capital expenditure outlook is estimated around Rs. 75-100 crore, primarily for sustenance and strategic areas mentioned.
→Multiple new conversations and explorations for the MPP (Multi-Purpose Project) are ongoing amidst tariff and market complexities but no specific commitments yet.

How does Rallis India Ltd rank vs peers in Fertilizers & Agrochemicals?

Pro feature

1Rallis India Ltd

Rev 4Mar 3

See full Fertilizers & Agrochemicals sector rankings

Want more stocks like Rallis India Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio